Betters(Suzhou) Medical Co., Ltd.

Betters(Suzhou) Medical Co., Ltd. specializes in microwave ablation systems, which include two primary components: non-powered probes and generator units. These devices are designed to deliver controlled microwave energy for tissue ablation, commonly used in medical procedures to treat tumors or other targeted tissues. The systems combine precision energy application with surgical tools to achieve therapeutic outcomes.

Betters(Suzhou) Medical Co., Ltd. is headquartered in the United States. The company’s location influences its regulatory compliance framework, particularly how its devices are authorised and monitored under US regulatory bodies like the FDA.

Betters(Suzhou) Medical Co., Ltd.’s devices fall under Class II classification by the FDA. This classification is typically assigned to devices that pose moderate risk and require special controls—such as performance standards or post-market surveillance—to ensure safety and effectiveness. Class II devices are authorised through pathways like the 510(k) premarket notification process, which demonstrates substantial equivalence to a legally marketed predicate device, or via UDI (Unique Device Identification) registrations to track devices throughout their lifecycle.

Betters(Suzhou) Medical Co., Ltd.’s devices are listed in the FDA’s 510(k) database and UDI (Unique Device Identifier) registry. These registries are critical for tracking authorised medical devices in the US, ensuring transparency in their design, manufacturing, and post-market performance. The inclusion in these databases reflects compliance with FDA requirements for device authorisation and traceability.

Betters(Suzhou) Medical Co., Ltd.’s microwave ablation systems are classified as Class II devices, which means they are subject to FDA oversight due to their role in medical procedures involving controlled energy delivery. The FDA’s authorisation process—such as the 510(k) pathway—ensures these devices meet safety and effectiveness standards before entering the market. This classification and regulatory pathway are designed to balance innovation with patient safety, particularly for devices that interact directly with the body during critical procedures.